Literature DB >> 18280864

Evidence for active closure of patent ductus arteriosus in very preterm infants.

David B Knight, Matthew M Laughon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280864     DOI: 10.1016/j.jpeds.2007.10.016

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

1.  Patent ductus arteriosus: indomethacin, Ibuprofen, surgery, or no treatment at all?

Authors:  Peter Gal
Journal:  J Pediatr Pharmacol Ther       Date:  2009-01

Review 2.  Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?

Authors:  Vassilios Fanos; Michele Pusceddu; Angelica Dessì; Maria Antonietta Marcialis
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  The effect of professional-led guideline workshops on clinical practice for the management of patent ductus arteriosus in preterm neonates in Japan: a controlled before-and-after study.

Authors:  Tetsuya Isayama; Xiang Y Ye; Hironobu Tokumasu; Hiroo Chiba; Hideko Mitsuhashi; Sadequa Shahrook; Satoshi Kusuda; Masanori Fujimura; Katsuaki Toyoshima; Rintaro Mori
Journal:  Implement Sci       Date:  2015-05-08       Impact factor: 7.327

4.  Timing of surgical ligation and morbidities in very low birth weight infants.

Authors:  YoungAh Youn; Cheong-Jun Moon; Jae-Young Lee; Cheul Lee; In Kyung Sung
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Patent ductus arteriosus ligation on neurodevelopmental outcomes at corrected 2 years.

Authors:  YoungAh Youn; Yu-Mi Seo; Sook-Kyung Yum; In Kyung Sung
Journal:  Ital J Pediatr       Date:  2019-08-23       Impact factor: 2.638

6.  Outcomes of primary ligation of patent ductus arteriosus compared with secondary ligation after pharmacologic failure in very-low-birth-weight infants.

Authors:  Young-Ah Youn; Cheong-Jun Moon; So-Young Kim; Jae Young Lee; In-Kyung Sung
Journal:  Pediatr Cardiol       Date:  2013-12-27       Impact factor: 1.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.